Figure 3 | Methodology and Application of Adaptive and Sequential Approaches in Contemporary Clinical Trials
How to design a dose-finding study using the continual reassessment method | BMC Medical Research Methodology | Full Text
The Classic 3 + 3 Design in Dose-finding Clinical Trials and Its Alternatives | Genpro Research
Interactive calculator for operating characteristics of phase I cancer clinical trials using standard 3+3 designs - ScienceDirect
Dose escalations methods used in phase I cancer clinical trials... | Download Scientific Diagram
CRM
Bayesian interval dose-finding designs: Methodology and Application
5 Reasons to Invest in Bayesian Dose-Escalation Methods
On Biostatistics and Clinical Trials: Phase I Dose Escalation Study Design: "3 + 3 Design"
Dose-finding designs for trials of molecularly targeted agents and immunotherapies
Comparative review of novel model‐assisted designs for phase I clinical trials - Zhou - 2018 - Statistics in Medicine - Wiley Online Library
Cancers | Free Full-Text | A Brief Overview of Adaptive Designs for Phase I Cancer Trials
Biostatistics Software Downloadable or Online
Early phase clinical trials to identify optimal dosing and safety - ScienceDirect
![PDF] Model-Based Dose Escalation Designs in R with crmPack | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/847192eed76efd88b33afbd2204f4d739d09b50a/3-Figure1-1.png "PDF] Model-Based Dose Escalation Designs in R with crmPack | Semantic Scholar")
PDF] Model-Based Dose Escalation Designs in R with crmPack | Semantic Scholar
Figure 4 from Dose Escalation Methods in Phase I Cancer Clinical Trials | Semantic Scholar
How to design a dose-finding study using the continual reassessment method | BMC Medical Research Methodology | Full Text
Assessment of various continual reassessment method models for dose- escalation phase 1 oncology clinical trials: using real clinical data and simulation studies | BMC Cancer | Full Text
Embracing model-based designs for dose-finding trials | British Journal of Cancer
Statistical controversies in clinical research: requiem for the 3 + 3 design for phase I trials - Annals of Oncology
Outline
On Biostatistics and Clinical Trials: Early Phase Trial to Find Maximal Tolerated Dose (MTD) - 3+3, CRM, and BOIN Designs
Dose-Finding Schemes in Clinical Trials
